 |
市場調查報告書 - 229163
肺部小細胞癌:全球臨床實驗檢討
Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2012
|
| 出版商 |
GlobalData |
| 出版日期 |
2012年06月30日 |
內容資訊 |
英文 Pages: 95 |
| 價格 |
|
|
肺部小細胞癌:全球臨床實驗檢討
Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2012
|
| 出版日期: 2012年06月30日 |
內容資訊: 英文 Pages: 95 |
|
|
簡介
本報告提供全球肺部小細胞癌治療藥物的臨床實驗的相關調查,各地區臨床實驗數資料,實驗階段,實驗情形,採用題目及各類型贊助企業的臨床實驗資料,中斷(暫時停止,廢止,停止)的實驗清單等資料,為您概述為以下內容。
目錄
- 目錄
- 簡介
- 臨床實驗 , 各地區
- 臨床實驗, 各國
- 對臨床實驗有所貢獻的前五國 - 亞太地區
- 對臨床實驗有所貢獻的前五國 - 歐洲
- 對臨床實驗有所貢獻的前幾名國家 - 北美
- 對臨床實驗有所貢獻的前幾名國家 - 中東及非洲
- 對臨床實驗有所貢獻的前五國 - 中南美
- 臨床實驗 - 金磚四國 各國
- 臨床實驗 - G7 各國
- 臨床實驗 - G7 各國 , 各臨床實驗狀態
- 臨床實驗 - E7 各國
- 臨床實驗 - E7 各國 , 各臨床實驗狀態
- 臨床實驗 各階段
- 進行中的臨床實驗 各階段
- 臨床實驗 , 各臨床實驗狀態
- 未完成的臨床實驗; 肺部小細胞癌
- 每段時期的實驗人數
- 有力的贊助商
- 前幾名參與企業 - 肺部小細胞癌 治療藥物的臨床實驗
- 潛力治療藥物比較
- 臨床實驗簡介
- 臨床實驗概要; 前幾名企業
- GlaxoSmithKline plc
- 臨床實驗概要; GlaxoSmithKline plc
- Eli Lilly and Company
- 臨床實驗概要; Eli Lilly and Company
- Hoosier Oncology Group, Inc.
- 臨床實驗概要; Hoosier Oncology Group, Inc.
- Bristol-Myers Squibb Company
- 臨床實驗概要; Bristol-Myers Squibb Company
- Celgene Corporation
- 臨床實驗概要; Celgene Corporation
- Pfizer Inc.
- 臨床實驗概要; Pfizer Inc.
- ImmunoGen, Inc.
- 臨床實驗概要; ImmunoGen, Inc.
- Amgen Inc.
- 臨床實驗概要; Amgen Inc.
- Bayer Inc.
- 臨床實驗概要; Bayer Inc.
- 日本化藥
- 臨床實驗概要; 日本化藥
- Abbott Laboratories
- 臨床實驗概要; Abbott Laboratories
- Sanofi
- 臨床實驗概要; Sanofi
- Novartis AG
- 臨床實驗概要; Novartis AG
- Astex Pharmaceuticals, Inc.
- 臨床實驗概要; Astex Pharmaceuticals, Inc.
- Poniard Pharmaceuticals, Inc.
- 臨床實驗概要; Poniard Pharmaceuticals, Inc.
- CHONG KUN DANG PHARMACEUTICAL CORP.
- 臨床實驗概要; CHONG KUN DANG PHARMACEUTICAL CORP.
- Cephalon, Inc.
- 臨床實驗概要; Cephalon, Inc.
- ImClone LLC
- 臨床實驗概要; ImClone LLC
- Oncology, Inc.
- 臨床實驗概要; Oncology, Inc.
- 武田藥品工業
- 臨床實驗概要; 武田藥品工業
- 臨床實驗概要; 最高級大學 / 研究機關 / 醫院
- European Organization for Research and Treatment of Cancer
- 臨床實驗概要; European Organization for Research and Treatment of Cancer
- The University of Texas M. D. Anderson Cancer Center
- 臨床實驗概要; The University of Texas M. D. Anderson Cancer Center
- Southeastern Medical Oncology Center
- 臨床實驗概要; Southeastern Medical Oncology Center
- Southwest Oncology Group
- 臨床實驗概要; Southwest Oncology Group
- Sarah Cannon Research Institute
- 臨床實驗概要; Sarah Cannon Research Institute
- H. Lee Moffitt Cancer Center & Research Institute
- 臨床實驗概要; H. Lee Moffitt Cancer Center & Research Institute
- Dana-Farber Cancer Institute
- 臨床實驗概要; Dana-Farber Cancer Institute
- Radiation Therapy Oncology Group
- 臨床實驗概要; Radiation Therapy Oncology Group
- Memorial Sloan Kettering Cancer Center
- 臨床實驗概要; Memorial Sloan Kettering Cancer Center
- National Cancer Center
- 臨床實驗概要; National Cancer Center
- Wake Forest University
- 臨床實驗概要; Wake Forest University
- Alberta Health Services
- 臨床實驗概要; Alberta Health Services
- Mayo Clinic
- 臨床實驗概要; Mayo Clinic
- Maastricht Radiation Oncology
- 臨床實驗概要; Maastricht Radiation Oncology
- Fox Chase Cancer Center
- 臨床實驗概要; Fox Chase Cancer Center
- University of Michigan Comprehensive Cancer Center
- 臨床實驗概要; University of Michigan Comprehensive Cancer Center
- University of Colorado
- 臨床實驗概要; University of Colorado
- UCLA's Jonsson Comprehensive Cancer Center
- 臨床實驗概要; UCLA's Jonsson Comprehensive Cancer Center
- Stanford University
- 臨床實驗概要; Stanford University
- Roswell Park Cancer Institute
- 臨床實驗概要; Roswell Park Cancer Institute
- 5大主要臨床簡介
附錄
- 簡稱
- 定義
- 調查方法
- 二級研究
- 關於GlobalData
- 諮詢方式
- 免責聲明
- 資訊來源
表格一覽
- 肺部小細胞癌 全球治療藥物市場, 臨床實驗 各地區
- 肺部小細胞癌 全球治療藥物市場, 臨床實驗 , 各國排名
- 肺部小細胞癌 全球治療藥物市場, 進行中的臨床實驗 , 各國排名
- 肺部小細胞癌 治療藥物的臨床實驗, 亞太地區, 前五國
- 肺部小細胞癌 治療藥物的臨床實驗, 歐洲, 前五國
- 肺部小細胞癌 治療藥物的臨床實驗, 北美, 前幾名國家
- 肺部小細胞癌 治療藥物的臨床實驗, 中東及非洲, 前幾名國家
- 肺部小細胞癌 治療藥物的臨床實驗, 中南美, 前五國
- 肺部小細胞癌 治療藥物的臨床實驗, 金磚四國 各國
- 肺部小細胞癌 治療藥物的臨床實驗, G7 各國
- 肺部小細胞癌 治療藥物市場, G7 各國, 臨床實驗 , 各臨床實驗狀態
- 肺部小細胞癌 治療藥物的臨床實驗, E7 各國
- 肺部小細胞癌 治療藥物市場, E7 各國, 臨床實驗 , 各臨床實驗狀態
- 肺部小細胞癌 全球治療藥物市場, 臨床實驗 各階段
- 肺部小細胞癌 全球治療藥物市場, 進行中的臨床實驗 各階段
- 肺部小細胞癌 全球治療藥物市場, 臨床實驗 , 各臨床實驗狀態
- 肺部小細胞癌 全球治療藥物市場, 暫時停止的臨床實驗
- 肺部小細胞癌 全球治療藥物市場, 中止的臨床實驗
- 肺部小細胞癌 全球治療藥物市場, 終止的臨床實驗
- 肺部小細胞癌 全球治療藥物臨床實驗, 平均登錄對像人數趨勢
- 肺部小細胞癌 全球治療藥物臨床實驗, 主要的贊助商
- 肺部小細胞癌 全球治療藥物臨床實驗, 前幾名企業 各階段
- 肺部小細胞癌 全球治療藥物臨床實驗, 臨床實驗, 各有潛力治療藥
- 肺部小細胞癌 全球治療藥物臨床實驗市場, 臨床實驗- GlaxoSmithKline plc
- 肺部小細胞癌 全球治療藥物臨床實驗市場, 臨床實驗- Eli Lilly and Company
- 肺部小細胞癌 全球治療藥物臨床實驗市場, 臨床實驗- Hoosier Oncology Group, Inc.
- 肺部小細胞癌 全球治療藥物臨床實驗市場, 臨床實驗- Bristol-Myers Squibb Company
- 肺部小細胞癌 全球治療藥物臨床實驗市場, 臨床實驗- Celgene Corporation
- 肺部小細胞癌 全球治療藥物臨床實驗市場, 臨床實驗- Pfizer Inc.
- 肺部小細胞癌 全球治療藥物臨床實驗市場, 臨床實驗- ImmunoGen, Inc.
- 肺部小細胞癌 全球治療藥物臨床實驗市場, 臨床實驗- Amgen Inc.
- 肺部小細胞癌 全球治療藥物臨床實驗市場, 臨床實驗- Bayer Inc.
- 肺部小細胞癌 全球治療藥物臨床實驗市場, 臨床實驗- 日本化藥
- 肺部小細胞癌 全球治療藥物臨床實驗市場, 臨床實驗- Abbott Laboratories
- 肺部小細胞癌 全球治療藥物臨床實驗市場, 臨床實驗- Sanofi
- 肺部小細胞癌 全球治療藥物臨床實驗市場, 臨床實驗- Novartis AG
- 肺部小細胞癌 全球治療藥物臨床實驗市場, 臨床實驗- Astex Pharmaceuticals, Inc.
- 肺部小細胞癌 全球治療藥物臨床實驗市場, 臨床實驗- Poniard Pharmaceuticals, Inc.
- 肺部小細胞癌 全球治療藥物臨床實驗市場, 臨床實驗- CHONG KUN DANG PHARMACEUTICAL CORP.
- 肺部小細胞癌 全球治療藥物臨床實驗市場, 臨床實驗- Cephalon, Inc.
- 肺部小細胞癌 全球治療藥物臨床實驗市場, 臨床實驗- ImClone LLC
- 肺部小細胞癌 全球治療藥物臨床實驗市場, 臨床實驗- Oncology, Inc.
- 肺部小細胞癌 全球治療藥物臨床實驗市場, 臨床實驗- 武田藥品工業
- 肺部小細胞癌 全球治療藥物臨床實驗市場, 臨床實驗- European Organization for Research and Treatment of Cancer
- 肺部小細胞癌 全球治療藥物臨床實驗市場, 臨床實驗- The University of Texas M. D. Anderson Cancer Center
- 肺部小細胞癌 全球治療藥物臨床實驗市場, 臨床實驗- Southeastern Medical Oncology Center
- 肺部小細胞癌 全球治療藥物臨床實驗市場, 臨床實驗- Southwest Oncology Group
- 肺部小細胞癌 全球治療藥物臨床實驗市場, 臨床實驗- Sarah Cannon Research Institute
- 肺部小細胞癌 全球治療藥物臨床實驗市場, 臨床實驗- H. Lee Moffitt Cancer Center & Research Institute
- 肺部小細胞癌 全球治療藥物臨床實驗市場, 臨床實驗- Dana-Farber Cancer Institute
- 肺部小細胞癌 全球治療藥物臨床實驗市場, 臨床實驗- Radiation Therapy Oncology Group
- 肺部小細胞癌 全球治療藥物臨床實驗市場, 臨床實驗- Memorial Sloan Kettering Cancer Center
- 肺部小細胞癌 全球治療藥物臨床實驗市場, 臨床實驗- National Cancer Center
- 肺部小細胞癌 全球治療藥物臨床實驗市場, 臨床實驗- Wake Forest University
- 肺部小細胞癌 全球治療藥物臨床實驗市場, 臨床實驗- Alberta Health Services
- 肺部小細胞癌 全球治療藥物臨床實驗市場, 臨床實驗- Mayo Clinic
- 肺部小細胞癌 全球治療藥物臨床實驗市場, 臨床實驗- Maastricht Radiation Oncology
- 肺部小細胞癌 全球治療藥物臨床實驗市場, 臨床實驗- Fox Chase Cancer Center
- 肺部小細胞癌 全球治療藥物臨床實驗市場, 臨床實驗- University of Michigan Comprehensive Cancer Center
- 肺部小細胞癌 全球治療藥物臨床實驗市場, 臨床實驗- University of Colorado
- 肺部小細胞癌 全球治療藥物臨床實驗市場, 臨床實驗- UCLA's Jonsson Comprehensive Cancer Center
- 肺部小細胞癌 全球治療藥物臨床實驗市場, 臨床實驗- Stanford University
- 肺部小細胞癌 全球治療藥物臨床實驗市場, 臨床實驗- Roswell Park Cancer Institute
圖表一覽
- 肺部小細胞癌 全球治療藥物市場, 臨床實驗 各地區 (%)
- 肺部小細胞癌 全球治療藥物市場, 臨床實驗 , 各國排名
- 肺部小細胞癌 全球治療藥物市場, 進行中的臨床實驗 , 各國排名
- 肺部小細胞癌 治療藥物的臨床實驗, 亞太地區, 前五國 (%)
- 肺部小細胞癌 治療藥物的臨床實驗, 歐洲, 前五國 (%)
- 肺部小細胞癌 治療藥物的臨床實驗, 北美, 前幾名國家 (%)
- 肺部小細胞癌 治療藥物的臨床實驗, 中東及非洲, 前幾名國家 (%)
- 肺部小細胞癌 治療藥物的臨床實驗, 中南美, 前五國 (%)
- 肺部小細胞癌 治療藥物的臨床實驗, 金磚四國 各國 (%)
- 肺部小細胞癌 治療藥物的臨床實驗, G7 各國 (%)
- 肺部小細胞癌 治療藥物市場, G7 各國, 臨床實驗 , 各臨床實驗狀態
- 肺部小細胞癌 治療藥物的臨床實驗, E7 各國 (%)
- 肺部小細胞癌 治療藥物市場, E7 各國, 臨床實驗 , 各臨床實驗狀態
- 肺部小細胞癌 全球治療藥物市場, 臨床實驗 各階段 (%)
- 肺部小細胞癌 全球治療藥物市場, 進行中的臨床實驗 各階段
- 肺部小細胞癌 全球治療藥物市場, 臨床實驗 , 各臨床實驗狀態
- 肺部小細胞癌 全球治療藥物臨床實驗, 平均登錄對像人數趨勢
- 肺部小細胞癌 全球治療藥物臨床實驗, 主要的贊助商
- 肺部小細胞癌 全球治療藥物臨床實驗, 前幾名企業 各階段
- 肺部小細胞癌 全球治療藥物臨床實驗, 臨床實驗, 各有潛力治療藥
- GlobalData 調查方法
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
目錄
Abstract
Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2012
Summary
GlobalData's clinical trial report, "Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2012" provides data on the Small-Cell Lung Cancer/Impaired Glucose Toleranceclinical trial scenario. This report provides elemental information and data relating to the clinical trials on Small-Cell Lung Cancer/Impaired Glucose Tolerance. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Small-Cell Lung Cancer/Impaired Glucose Tolerance. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Keywords
Small-Cell Lung Cancer/Impaired Glucose Tolerance Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Small-Cell Lung Cancer/Impaired Glucose Tolerance, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.
TOC
Table of Contents
Table of Contents 2
- List of Tables 5
- List of Figures 7
- Introduction 8
- Small-Cell Lung Cancer 8
- Report Guidance 8
- Clinical Trials by Region 9
- Clinical Trials by Country 10
- Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
- Top Five Countries Contributing to Clinical Trials in Europe 13
- Top Countries Contributing to Clinical Trials in North America 14
- Top Countries Contributing to Clinical Trials in Middle East and Africa 15
- Top Five Countries Contributing to Clinical Trials in Central and South America 16
- Clinical Trials by BRIC Nations 17
- Clinical Trials by G7 Nations 18
- Clinical Trials in G7 Nations by Trial Status 19
- Clinical Trials by E7 Nations 20
- Clinical Trials in E7 Nations by Trial Status 21
- Clinical Trials by Phase 22
- In Progress Trials by Phase 23
- Clinical Trials by Trial Status 24
- Unaccomplished Trials of Small-Cell Lung Cancer 25
- Subjects Recruited Over a Period of Time 30
- Prominent Sponsors 31
- Top Companies Participating in Small-Cell Lung Cancer Therapeutics Clinical Trials 33
- Prominent Drug Comparison 35
- Clinical Trial Profiles 36
- Clinical Trial Overview of Top Companies 36
- GlaxoSmithKline plc 36
- Clinical Trial Overview of GlaxoSmithKline plc 36
- Eli Lilly and Company 37
- Clinical Trial Overview of Eli Lilly and Company 37
- Bristol-Myers Squibb Company 38
- Clinical Trial Overview of Bristol-Myers Squibb Company 38
- Celgene Corporation 39
- Clinical Trial Overview of Celgene Corporation 39
- Pfizer Inc. 40
- Clinical Trial Overview of Pfizer Inc. 40
- ZIOPHARM Oncology, Inc. 41
- Clinical Trial Overview of ZIOPHARM Oncology, Inc. 41
- ImmunoGen, Inc. 42
- ImmunoGen, Inc. 42
- Clinical Trial Overview of ImmunoGen, Inc. 42
- Amgen Inc. 43
- Clinical Trial Overview of Amgen Inc. 43
- Bayer Inc. 44
- Clinical Trial Overview of Bayer Inc. 44
- Abbott Laboratories 45
- Clinical Trial Overview of Abbott Laboratories 45
- Sanofi 46
- Clinical Trial Overview of Sanofi 46
- Nippon Kayaku Co., Ltd. 47
- Clinical Trial Overview of Nippon Kayaku Co., Ltd. 47
- Astex Pharmaceuticals, Inc. 48
- Clinical Trial Overview of Astex Pharmaceuticals, Inc. 48
- Merck KGaA 49
- Clinical Trial Overview of Merck KGaA 49
- Poniard Pharmaceuticals, Inc. 50
- Clinical Trial Overview of Poniard Pharmaceuticals, Inc. 50
- UAB Health System 51
- Clinical Trial Overview of UAB Health System 51
- CHONG KUN DANG PHARMACEUTICAL CORP. 52
- Clinical Trial Overview of CHONG KUN DANG PHARMACEUTICAL CORP. 52
- Cephalon, Inc. 53
- Clinical Trial Overview of Cephalon, Inc. 53
- ImClone LLC 54
- Clinical Trial Overview of ImClone LLC 54
- Novartis AG 55
- Clinical Trial Overview of Novartis AG 55
- Clinical Trial Overview of Top Universities / Institutes / Hospitals 56
- The University of Texas M. D. Anderson Cancer Center 56
- Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 56
- Southeastern Medical Oncology Center 57
- Clinical Trial Overview of Southeastern Medical Oncology Center 57
- Sarah Cannon Research Institute 58
- Clinical Trial Overview of Sarah Cannon Research Institute 58
- H. Lee Moffitt Cancer Center & Research Institute 59
- Clinical Trial Overview of H. Lee Moffitt Cancer Center & Research Institute 59
- Dana-Farber Cancer Institute 60
- Clinical Trial Overview of Dana-Farber Cancer Institute 60
- Wake Forest University 61
- Clinical Trial Overview of Wake Forest University 61
- Memorial Sloan Kettering Cancer Center 62
- Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 62
- Maastricht Radiation Oncology 63
- Clinical Trial Overview of Maastricht Radiation Oncology 63
- Mayo Clinic 64
- Clinical Trial Overview of Mayo Clinic 64
- Fox Chase Cancer Center 65
- Clinical Trial Overview of Fox Chase Cancer Center 65
- University of Michigan Comprehensive Cancer Center 66
- Clinical Trial Overview of University of Michigan Comprehensive Cancer Center 66
- University of Colorado 67
- Clinical Trial Overview of University of Colorado 67
- UCLA's Jonsson Comprehensive Cancer Center 68
- Clinical Trial Overview of UCLA's Jonsson Comprehensive Cancer Center 68
- Stanford University 69
- Clinical Trial Overview of Stanford University 69
- Roswell Park Cancer Institute 70
- Clinical Trial Overview of Roswell Park Cancer Institute 70
- Case Comprehensive Cancer Center 71
- Clinical Trial Overview of Case Comprehensive Cancer Center 71
- UH Seidman Cancer Center 72
- Clinical Trial Overview of UH Seidman Cancer Center 72
- Vanderbilt-Ingram Cancer Center 73
- Clinical Trial Overview of Vanderbilt-Ingram Cancer Center 73
- Norris Cotton Cancer Center 74
- Clinical Trial Overview of Norris Cotton Cancer Center 74
- Tohoku University 75
- Clinical Trial Overview of Tohoku University 75
- Five Key Clinical Profiles 76
Appendix 92
- Abbreviations 92
- Definitions 92
- Research Methodology 93
- Secondary Research 93
- About GlobalData 94
- Contact Us 94
- Disclaimer 94
- Source 95
List of Tables
List of Tables
- Small-Cell Lung Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2012* 9
- Small-Cell Lung Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10
- Small-Cell Lung Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11
- Small-Cell Lung Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 12
- Small-Cell Lung Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 13
- Small-Cell Lung Cancer Therapeutics Clinical Trials, North America, Top Countries, 2012* 14
- Small-Cell Lung Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 15
- Small-Cell Lung Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012* 16
- Small-Cell Lung Cancer Therapeutics Clinical Trials, BRIC Countries, 2012* 17
- Small-Cell Lung Cancer Therapeutics Clinical Trials, G7 Countries, 2012* 18
- Small-Cell Lung Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19
- Small-Cell Lung Cancer Therapeutics Clinical Trials, E7 Countries, 2012* 20
- Small-Cell Lung Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21
- Small-Cell Lung Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2012* 22
- Small-Cell Lung Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 23
- Small-Cell Lung Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24
- Small-Cell Lung Cancer Therapeutics Market, Global, Suspended Clinical Trials, 2012* 25
- Small-Cell Lung Cancer Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 26
- Small-Cell Lung Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2012* 27
- Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 30
- Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 32
- Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 34
- Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 35
- Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012* 36
- Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012* 37
- Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2012* 38
- Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2012* 39
- Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 40
- Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by ZIOPHARM Oncology, Inc., 2012* 41
- Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by ImmunoGen, Inc., 2012* 42
- Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2012* 43
- Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer Inc., 2012* 44
- Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2012* 45
- Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012* 46
- Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Nippon Kayaku Co., Ltd., 2012* 47
- Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Astex Pharmaceuticals, Inc., 2012* 48
- Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck KGaA, 2012* 49
- Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Poniard Pharmaceuticals, Inc., 2012* 50
- Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by UAB Health System, 2012* 51
- Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by CHONG KUN DANG PHARMACEUTICAL CORP., 2012* 52
- Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Cephalon, Inc., 2012* 53
- Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by ImClone LLC, 2012* 54
- Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 55
- Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012* 56
- Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Southeastern Medical Oncology Center, 2012* 57
- Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarah Cannon Research Institute, 2012* 58
- Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lee Moffitt Cancer Center & Research Institute, 2012* 59
- Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2012* 60
- Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2012* 61
- Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012* 62
- Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht Radiation Oncology, 2012* 63
- Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012* 64
- Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Fox Chase Cancer Center, 2012* 65
- Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan Comprehensive Cancer Center, 2012* 66
- Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado, 2012* 67
- Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by UCLA's Jonsson Comprehensive Cancer Center, 2012* 68
- Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2012* 69
- Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2012* 70
- Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2012* 71
- Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by UH Seidman Cancer Center, 2012* 72
- Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt-Ingram Cancer Center, 2012* 73
- Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Norris Cotton Cancer Center, 2012* 74
- Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Tohoku University, 2012* 75
List of Figures
List of Figures
- Small-Cell Lung Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 9
- Small-Cell Lung Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10
- Small-Cell Lung Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11
- Small-Cell Lung Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 12
- Small-Cell Lung Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 13
- Small-Cell Lung Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 14
- Small-Cell Lung Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012* 15
- Small-Cell Lung Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012* 16
- Small-Cell Lung Cancer Therapeutics Clinical Trials, BRIC Countries (%), 2012* 17
- Small-Cell Lung Cancer Therapeutics Clinical Trials, G7 Countries (%), 2012* 18
- Small-Cell Lung Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19
- Small-Cell Lung Cancer Therapeutics Clinical Trials, E7 Countries (%), 2012* 20
- Small-Cell Lung Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21
- Small-Cell Lung Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 22
- Small-Cell Lung Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 23
- Small-Cell Lung Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24
- Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 30
- Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 31
- Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 33
- Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 35
- GlobalData Methodology 93
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
肺部小細胞癌:全球臨床實驗檢討是由出版商GlobalData在2012年06月30日所出版的。這份市場調查報告書包含Pages: 95 價格從美金2500起跳。
|

|
02-2729-4219 +886-2-2729-4219
|